These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 12126893)

  • 21. Hepatitis B vaccine for infants of HBsAg-positive mothers.
    Kripke C
    Am Fam Physician; 2007 Jan; 75(1):49-50. PubMed ID: 17225703
    [No Abstract]   [Full Text] [Related]  

  • 22. Hepatitis B vaccination coverage and risk factors associated with incomplete vaccination of children born to hepatitis B surface antigen-positive mothers, Denmark, 2006 to 2010.
    Kunoee A; Nielsen J; Cowan S
    Euro Surveill; 2016; 21(7):pii=30136. PubMed ID: 26923681
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The pediatrician and the hepatitis B vaccine].
    Mussa GC; Silvestro L; Mussa F
    Minerva Pediatr; 1994 Nov; 46(11):475-80. PubMed ID: 7870007
    [No Abstract]   [Full Text] [Related]  

  • 24. Duration of immune protection after hepatitis B vaccine in newborns from HBsAg-positive carrier mothers.
    Belloni C; Orsolini P; Soldini L; Campisi D; Chiesa A; Ciceri R; Filice G
    Microbiologica; 1991 Jul; 14(3):195-8. PubMed ID: 1833611
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cost-effectiveness of prenatal screening and immunization for hepatitis B virus.
    Arevalo JA; Washington AE
    JAMA; 1988 Jan; 259(3):365-9. PubMed ID: 2961895
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Improved immunization practices reduce childhood hepatitis B infection in Tonga.
    Danielsson N; Fakakovikaetau T; Szegedi E
    Vaccine; 2009 Jul; 27(33):4462-7. PubMed ID: 19508908
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Implementing universal vaccination programmes: USA.
    Kane M
    Vaccine; 1995; 13 Suppl 1():S75-6. PubMed ID: 7571840
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sero prevalence of hepatitis B surface antigen (HBsAg) in pregnant women in Southeast Nigeria.
    Ikeme AC; Ezegwui HU; Ogbonna C
    Trop Doct; 2006 Apr; 36(2):128. PubMed ID: 16611460
    [No Abstract]   [Full Text] [Related]  

  • 29. Familial clustering of hepatitis B virus infections and prevention of perinatal transmission by immunization with a reduced number of doses in an area of intermediate endemicity (Tunisia).
    Coursaget P; Gharbi Y; Khrouf N; Depril N; Boukhris N; Fritzell B; Kastally R
    Vaccine; 1994; 12(3):275-8. PubMed ID: 8165860
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Applicability and efficacy of a model for prevention of perinatal transmission of hepatitis B virus infection: single center study in Egypt.
    El-Karaksy HM; Mohsen LM; Saleh DA; Hamdy MS; Yassin NA; Farouk M; Salit ME; El-Shabrawi MH
    World J Gastroenterol; 2014 Dec; 20(45):17075-83. PubMed ID: 25493019
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Clinical study of fulminant hepatitis B in infants caused by mother-to-infant infection].
    Iitsuka T; Nagata I; Kanzaki S
    Nihon Rinsho; 2004 Aug; 62 Suppl 8():274-9. PubMed ID: 15453329
    [No Abstract]   [Full Text] [Related]  

  • 32. [Vertical HBV transmission in Jerusalem in the vaccine era].
    Michaiel R; Margalit RC; Shteyer E; Ashur Y; Safadi R
    Harefuah; 2012 Dec; 151(12):671-4, 722, 721. PubMed ID: 23330257
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Confusing games of public insurance with hepatitis B vaccinations. Interview by Dr. rer. nat. Anita Schweiger].
    Eichhorn R
    Fortschr Med; 1997 Apr; 115(10):41. PubMed ID: 9206686
    [No Abstract]   [Full Text] [Related]  

  • 34. [Screening for hepatitis B in pregnancy and sequelae for the newborn infant].
    Albrecht K
    Z Geburtshilfe Neonatol; 1995; 199(6):253-6. PubMed ID: 8581852
    [No Abstract]   [Full Text] [Related]  

  • 35. [Influencing factors for non/low-response to hepatitis-B vaccine in infants of HBsAg positive mothers].
    Wang B; Xu XX; Wen HX; Hao HY; Yang ZQ; Shi XH; Fu ZD; Wang XF; Zhang F; Wang B; Wang SP
    Zhonghua Liu Xing Bing Xue Za Zhi; 2017 Jul; 38(7):911-915. PubMed ID: 28738465
    [No Abstract]   [Full Text] [Related]  

  • 36. Persistent and transient hepatitis B virus (HBV) infections in children born to HBV-infected mothers despite active and passive vaccination.
    Boot HJ; Hahné S; Cremer J; Wong A; Boland G; van Loon AM
    J Viral Hepat; 2010 Dec; 17(12):872-8. PubMed ID: 20051008
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hepatitis B vaccines: WHO position paper – July 2017.
    Wkly Epidemiol Rec; 2017 Jul; 92(27):369-92. PubMed ID: 28685564
    [No Abstract]   [Full Text] [Related]  

  • 38. [Economic evaluation and prediction of hepatitis B immunization strategy in Shenzhen, China].
    Sun PP; Zhang SX; Xia Y
    Zhonghua Yu Fang Yi Xue Za Zhi; 2018 Jul; 52(7):743-747. PubMed ID: 29996303
    [No Abstract]   [Full Text] [Related]  

  • 39. Perinatal transmission of hepatitis B virus: could hospitals be doing more?
    Zhang F; Zhang Y
    Expert Rev Anti Infect Ther; 2010 Jul; 8(7):735-8. PubMed ID: 20586557
    [No Abstract]   [Full Text] [Related]  

  • 40. Quantitative analysis of HBV DNA level and HBeAg titer in hepatitis B surface antigen positive mothers and their babies: HBeAg passage through the placenta and the rate of decay in babies.
    Wang Z; Zhang J; Yang H; Li X; Wen S; Guo Y; Sun J; Hou J
    J Med Virol; 2003 Nov; 71(3):360-6. PubMed ID: 12966540
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.